The Oral Mucositis Market forecast is poised for substantial expansion over the coming years, primarily propelled by the continuously escalating patient pool undergoing cancer therapies worldwide. With chemotherapy and radiation remaining central pillars of oncology treatment, the unavoidable incidence of oral mucositis (OM) in high-risk patient groups, such as those with hematologic...